Zimbabwe has turned down a substantial American health deal valued at $367m (£272m) spanning five years due to Washington's request for sensitive biological samples.
This rejection became public after a official document from December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".
A government spokesperson later stated that the United States was requesting biological samples for scientific study and profit but was not willing to guarantee the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for more talks to secure a deal suitable to all parties so the country's critical HIV programme can be sustained.
Wider Implications
This rejection follows a comparable situation in neighbouring Kenya, where a high court blocked a related deal with the US after concerns were filed about the security of citizens' health data.
After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had overseen aid for the American government, but Trump stated its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance transparency and responsibility.
According to statements, Sixteen nations in Africa have to date signed these new agreements, representing over $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this collaboration might have yielded significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to surrender its biological resources and data for a long time, without any corresponding guarantee of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Effectively, our country would provide the basic resources for medical research with no assurance that the end products would be available to our citizens should a new pandemic arise."
Sovereignty and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already established through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system designed to manage potential pandemics.
"This framework is intended to ensure that when a nation contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to ongoing dialogue with our American counterparts on how future collaboration could be arranged in a way that respects the sovereignty and interests of each country."
Medical Community Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the official position, but urged that negotiations need to persist given that much of the country's HIV programmes depended on external financing.
"If technical issues exist, including those involving data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group said.
The situation underscores the complex debate between accepting crucial international aid and protecting local interests in an increasingly interconnected world.